期刊文献+

淋病奈瑟菌疫苗的研究进展

Advances in research on Neisseria gonorrhoeae vaccines
原文传递
导出
摘要 淋病是由淋病奈瑟菌引起的一种性传播疾病,其感染率高,传染性强。淋病奈瑟菌菌体结构复杂,抗原变异性较强,对抗生素的耐药率不断上升,多重耐药表型也广泛出现,导致淋病治疗后易复发。因此,淋病疫苗的研发成了从源头上预防和杜绝淋病的重要环节。本文从淋病奈瑟菌的蛋白组学疫苗、糖组学相关的疫苗和DNA疫苗等方面的研究进展进行综述,为淋病疫苗的研制提供思路和理论依据。 Gonorrhea is a sexually transmitted disease caused by Neisseria gonorrhoeae,which has a high rate of infection and which is highly contagious.N.gonorrhoeae has a complex structure,extensive antigenic variability,and increasing resistance to antibiotics.The multidrug-resistant phenotype of N.gonorrhoeae is widespread,readily leading to recurrence after treatment of gonorrhea.Therefore,the development of gonorrhea vaccines has become an important part of preventing and eliminating gonorrhea at the source.This review summarizes advances in research proteomics vaccines,glycomics-related vaccines,and DNA vaccines against N.gonorrhoeae,and it provides ideas and a theoretical basis for the development of gonorrhea vaccines.
作者 杨梅 张雷 YANG Mei;ZHANG Lei(Integrated Laboratory of Pathogen Biology,School of Preclinical Medicine,Dali University,Yunnan,China 671000)
出处 《中国病原生物学杂志》 CSCD 北大核心 2019年第9期1112-1114,共3页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No.81760303) 大理大学临床分子免疫学创新团队(No.ZKLX2019105)
关键词 淋病奈瑟菌 蛋白组学疫苗 糖组学疫苗 DNA疫苗 反向疫苗学 综述 Neisseria gonorrhoeae proteomic vaccine glycomics vaccine DNA vaccine reverse vaccinology review
  • 相关文献

参考文献5

二级参考文献68

  • 1袁源,王栋,邢丽,王希良.不同佐剂与鼠疫F1-V融合重组蛋白抗原滴鼻免疫效果的研究[J].免疫学杂志,2009(2):183-186. 被引量:2
  • 2李平忠,郭宏雄.DNA疫苗和细胞凋亡[J].国外医学(预防.诊断.治疗用生物制品分册),2004,27(5):218-220. 被引量:1
  • 3刘浩,姜广水.凋亡基因与DNA疫苗[J].现代免疫学,2004,24(6):520-522. 被引量:1
  • 4张冉,易新元,曾宪芳,张顺科,蔡春,Larry McReynolds.日本血吸虫Rho GTPase DNA疫苗及重组蛋白疫苗免疫保护机制初探[J].中国寄生虫病防治杂志,2004,17(5):291-294. 被引量:3
  • 5Unemo M, Palmer HM, Blackmore T, et al. Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies. Sexually Transmitted Infections, 2007, 83(1) :47-51.
  • 6Zhu W, Thomas CE, Chen C J, et al. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles. Infection and Immunity, 2005, 73 ( 11 ) :7558-7568.
  • 7Pizza M, Giuliani MM, Fontana MR, et al. Mucosal vaccines: nontoxic derivatives of LT and CT as mucosal adjuvants. Vaccine, 2001, 19(17-19) :2534 - 2541.
  • 8Spangler BD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiological Reviews, 1992, 56 ( 4 ) : 622-647.
  • 9Verweij WR, de Haan L, Holtrop M, et al. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine, 1998, 16(20):2069-2076.
  • 10O' Dowd AM, Botting CH, Precious B, et al. Novel modifications to the C-terminus of LTB that facilitate sitedirected chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccines. Vaccine, 1999, 17(11-12) : 1442-1453.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部